Spruce Biosciences annual operating margin
2023
2024
Spruce Biosciences Operating Margin Growth & History (SPRB)
Spruce Biosciences's operating margin was −1,143.37% for fiscal 2024.
View full Spruce Biosciences company overviewSpruce Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −1,143.37% | −628.03 pp |
| 2023 | 2023-12-31 | −515.34% | — |
Spruce Biosciences quarterly operating margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −3,453.95% | −3067.25 pp |
| Q3 2024 | 2024-09-30 | −1,562.79% | −1118.34 pp |
| Q2 2024 | 2024-06-30 | −623.35% | +22.00 pp |
| Q1 2024 | 2024-03-31 | −631.02% | +41.03 pp |
| Q4 2023 | 2023-12-31 | −386.70% | — |
| Q3 2023 | 2023-09-30 | −444.45% | — |
| Q2 2023 | 2023-06-30 | −645.36% | — |
| Q1 2023 | 2023-03-31 | −672.05% | — |
Spruce Biosciences operating margin trends
Across the available reported history, Spruce Biosciences's operating margin decreased from −515.34% to −1,143.37%, a change of −628.03 percentage points. The latest reported quarter, Q4 2024, shows −3,453.95%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spruce Biosciences filings at SEC.gov ↗